Heading to #ECP2024 in Florence? We’re thrilled to meet you there! Visit our team at booth #4 to explore our cutting-edge AI-powered solutions designed for both clinical and research applications. Engage in face-to-face discussions on how digital pathology can support your clinical workflows and elevate cancer diagnostics to a new standard. #ECP2024 #aihealthcare #biotech #digitalhealth #healthcareinnovation #pathology
Mindpeak GmbH
IT und Services
Our mission is to enable personalised cancer treatment through AI tissue diagnostics
Info
Mindpeak's mission is to enable personalised cancer treatment through AI tissue diagnostics Our partners are leading pathology and university labs. Our team consists of world-class industry experts in machine learning and company building. Mindpeak's Impact The demand for medical image analysis is growing rapidly but the number of cancer experts remains the same - this results in growing workloads per specialist. We help cancer experts meet this challenge. We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. If you want to get in touch with us send us an E-Mail via [email protected].
- Website
-
https://www.mindpeak.ai/
Externer Link zu Mindpeak GmbH
- Branche
- IT und Services
- Größe
- 11–50 Beschäftigte
- Hauptsitz
- Hamburg
- Art
- Privatunternehmen
- Gegründet
- 2018
Orte
-
Primär
Zirkusweg 2
Hamburg, 20359, DE
Beschäftigte von Mindpeak GmbH
Updates
-
📢 Welcome to the team, Maria Holm! 📢 We are delighted to welcome Maria Holm as our new Strategic Project Manager. Maria comes with an impressive track record, including five years at Airbus. Her academic background includes a Bachelor of Applied Science from the International School of Management, Germany and a Master's in Controlling and Business Management from Hochschule Fresenius, which further underscores her strategic understanding and management skills. Maria will leverage her expertise in project coordination and strategic management to advance our AI-driven company for digital pathology. With mindpeak onboarding more and more customers and making big steps in the product development, structure and strategic mindset becomes increasingly important. We are confident that Maria’s deep insights and leadership will significantly contribute to the success of mindpeak in the next growth phase. Please join us in warmly welcoming Maria as she embarks on this exciting journey with us! #TeamMindpeak #digitalpathology #aihealthcare #biotech #pathology
-
-
Meet our experts at ASCO! We’ll be at #ASCO2024 and we are looking forward to many in-person meetings to discuss digital pathology in pharma research and clinical development from biomarker readout, over biomarker development and patient stratification to outcome prediction. Please drop JT Ward and David Mulder a DM for a meeting! Mindpeak GmbH's AI is featured in a poster: - 2633, Saturday 6/1/2024: Sunil S. Badve, MD, FRCPath et al. – AI based PD-L1 CPS quantifier software to identify more patients for checkpoint therapy in gastric cancer at pathologist-level interobserver concordance. Our oncology AIs for #PDL1, #HER2,… are already in clinical use in the US and EU! #aihealthcare #biomarker #novelbiomarker #pharmaceuticals #biotech #digitalpathology #pathology #research #networking
-
-
Coming to #ESMO Breast Cancer 2024 in Berlin this week? Meet Mindpeak GmbH's experts Patrick Frey and David Mulder to discuss how our AI algorithms can revolutionize breast cancer diagnostics. Also, make sure to check out Poster 66P on Thursday! Together with PD Dr. med. habil. Ramona Erber and Memorial Healthcare Group, we present on the performance of our new TNBC PD-L1 scoring algorithm - the first fully-automated AI software that is non-inferior to pathologists in breast cancer PD-L1 CPS scoring! Looking forward to seeing you in Berlin! #ESMOBreast #breastcancer #tnbc #pdl1 #aihealthcare #digitalpathology #biomarkers #mindpeak
-
-
Meet our experts at #EWC24! Mindpeak GmbH is attending Executive War College 2024! Meet up with our CEO Felix Faber and our Director of Diagnostic Sales Erik Piorkowski to connect and discuss how our pathology #AI solutions improve clinical diagnostic workflows. Looking forward to seeing you in #NOLA! #executivewarcollege #EWC24 #ai #aihealthcare #digitalpathology #biomarkers #laboratorymedicine #pathology #diagnostics #mindpeak
-
-
Meet our experts at AACR! Attending #AACR24 in San Diego (CA, USA) and interested in tailored AI solutions for biomarker readout, digital biomarkers, patient identification and outcome prediction based on pathology images? Just drop JT Ward and Dr. Anil Berger Berger a DM to discuss how our AI platform can support your needs! Mindpeak GmbH’s AI software is featured in a poster (TUE 9 Apr 1:30-5:00pm): - Section 35, Posterboard 8: Robust PD-L1 scoring in UC with multiple antibodies, scanners and centers (Universitätsklinikum Erlangen, Niklas Abele et al.) #aihealthcare #biomarker #novelbiomarker #pharmaceuticals #biotech #digitalpathology #pathology #research #networking
-
-
Meet our experts at USCAP! We are looking forward to meeting you in person at #USCAP2024, Baltimore (MD), USA. Meet our CEO Felix Faber and our experts Patrick Frey, Timm Gömpel at our booth (no 863). Our 0-Click solutions automatically segment the tissue to identify invasive tumor areas, find and quantify tumor cells there and apply the respective scoring guideline per biomarker to directly propose a score for the whole-slide-image together with single-cell results for final review. In addition there are 2 posters with Mindpeak GmbH's AIs (27 Mar, 9:30-12:00): - poster board 12 (Unilabs, MD PhD Eugenia Colón): improved inter-reader agreement on breast biomarkers - poster board 29 (Discovery Life Sciences, Hans-Ulrich Schildhaus): AI-based virtual biopsy model predicts minimum number of breast biopsies to reliably predict HER2low status #aihealthcare #cancerdiagnosis #digitalpathology #pathology #USCAP2024
-
-
We at Mindpeak GmbH are happy to contribute our leading pathology AI algorithms as well as our expertise in the development of new AI to the Proscia Ready Programme in order to offer our joint customers an optimal user experience right from the start. #digitalpathology #precisionmedicine #biomarkers #aihealthcare #biotech #pathology #lifesciences
Introducing Proscia Ready! We've formed a new partner alliance to help life sciences organizations and diagnostic laboratories accelerate the scaled adoption of #digitalpathology with confidence. Learn more below and in our press release about how we're teaming up with Barco, Dell Technologies, DoMore Diagnostics, Hamamatsu Corporation, Ibex Medical Analytics, Mindpeak GmbH, Stratipath, and Visiopharm. https://bit.ly/3T2U1we
-
🌟 Welcome to the team, Timm Gömpel! 🌟 We're delighted to have Timm Gömpel join us as our General Management & Entrepreneurship Resident. With an impressive track record that includes stints at Boston Consulting Group (BCG), Buynomics, and A.P. Møller Capital, Timm brings a wealth of experience. His academic background from the Universität St.Gallen (HSG) and Copenhagen Business School adds a layer of strategic depth to his already formidable expertise in product management, strategy, and innovation. Timm's arrival promises to invigorate our team dynamic. His ability to shape and execute product vision and strategy sets him apart and positions him as an invaluable asset to our management team. We have no doubt that Timm's deep insight and leadership will be the driving force behind Mindpeak GmbH's unprecedented success. Please join us in welcoming Timm as he embarks on this exciting journey with us! #digitalpathology #precisionmedicine #biomarkers #aihealthcare #biotech #pathology #lifesciences
-
-
Meet our CEO Felix Faber in San Francisco from Jan 8-11 during the J.P. Morgan conference. Looking forward to discuss the future of pathology, AI-biomarkers and precision medicine! #JPM2024 #digitalpathology #precisionmedicine #biomarkers #aihealthcare #biotech #pathology #lifesciences
-